Workflow
和铂医药-B10月14日斥资386.95万港元回购30万股

Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 3.8695 million to repurchase 300,000 shares [1] - The buyback is scheduled for October 14, 2025, reflecting a strategic move to enhance shareholder value [1]